...
机译:微观淋巴血管入侵是切除胰腺导管腺癌中生存的独立预测因素
Sidney Kimmel Medical College at Thomas Jefferson UniversityPhiladelphia Pennsylvania;
Department of SurgeryThomas Jefferson University HospitalPhiladelphia Pennsylvania;
Department of SurgeryMassachusetts General HospitalBoston Massachusetts;
Department of Surgical OncologyJohns Hopkins HospitalBaltimore Maryland;
Department of Surgical OncologyJohns Hopkins HospitalBaltimore Maryland;
Department of PathologyThomas Jefferson University HospitalPhiladelphia Pennsylvania;
Department of PathologyThomas Jefferson University HospitalPhiladelphia Pennsylvania;
Department of SurgeryMassachusetts General HospitalBoston Massachusetts;
Department of SurgeryMassachusetts General HospitalBoston Massachusetts;
Department of Surgical OncologyJohns Hopkins HospitalBaltimore Maryland;
Department of Surgical OncologyJohns Hopkins HospitalBaltimore Maryland;
Department of SurgeryThomas Jefferson University HospitalPhiladelphia Pennsylvania;
Department of SurgeryThomas Jefferson University HospitalPhiladelphia Pennsylvania;
Department of SurgeryMassachusetts General HospitalBoston Massachusetts;
Department of Surgical OncologyJohns Hopkins HospitalBaltimore Maryland;
Department of SurgeryThomas Jefferson University HospitalPhiladelphia Pennsylvania;
cancer; LVI; microscopic lymphovascular invasion; pancreatic ductal adenocarcinoma; prognosis; survival;
机译:微观淋巴血管入侵是切除胰腺导管腺癌中生存的独立预测因素
机译:高质量的SPARC表达与用佐剂吉西他滨治疗的切除胰腺导管腺癌的患者的差与单独的S-1或佐剂吉西他滨组合单独相关
机译:术前血液学指标作为切除的胰管腺癌预后的独立预测指标:中性粒细胞-淋巴细胞与血小板-淋巴细胞的比率。
机译:纹理分析对胰腺癌新辅助化疗患者生存率的预测
机译:Ca19-9抗原和stra聚糖定义独立的胰腺导管腺癌群,提高了预后分类的诊断准确性和方法
机译:基于PD-L2的免疫标记物特征有助于预测切除的胰管腺癌的存活率
机译:切除胰腺导管腺癌的早期阶段和侵入性导管乳头状粘膜肿瘤,不同于临床病理特征和生存?